Background. Peripheral diabetic polyneuropathy (DPN) is one of the most frequent neurological complications of diabetes mellitus (DM).
Introduction
Peripheral diabetic polyneuropathy (DPN) is a typical early and most frequent complication of diabetes mellitus (DM) [1] . It develops due to affection of nerve fibers, caused by diabetes and occurs in more than 50 % of patients with this illness. Polyneuropathy is revealed in both young and elderly patients with type 1 and type 2 diabetes mellitus [2] . There is no single classification of peripheral diabetic neuropathy. Some authors recommend defining hypohyperglycemic, generalized, focal and multifocal types (Thomas P.K. 1997); whereas others insist on singling outing asymptomatic, symptomatic and marked symptoms (Dyck P. J. 1999) or mono, polyneuropathy and autonomic polyneuropathy (I. I. Dedov et al., 2002) . According to the protocol of medical care [11] , peripheral polyneuropathy is divided into somatic (motor, sensory and sensory-motor), vegetative and mononeuropathy.
To diagnose pathological process in the nervous tissue Boulton et al (2005) suggested allocating three clinical forms of peripheral DPN (silent, acute pain and chronic pain). Chronic pain form of DPN is the most commonly reveled in the patients with diabetes [1] .
The severity of this complication depends on its clinical consequences, in particular, trophic disorders and neuropathic pain, which adversely affect patients' quality of life. A number of questionnaires are used to diagnose neuropathic pain [3] . DN4 questionnaire, being one of the most practical, where a positive response to four or more questions out of ten substantiates 'neuropathic pain' diagnosis, is used as a screening to detect neuropathic pain syndromes [4] .
Despite the large number of pharmacological agents, treatment of patients with diabetic polyneuropathy is not sufficiently effective [5, 6, 7] , which necessitates the search for new methods of treatment. Since the mid-80s, there have been physiotherapeutic devices that emit visible (wavelength 80-3400 nm) linearly polarized (95 %) incoherent (desynchronized in time and space) low-energy (non-destructive, with the energy flux intensity of 40 mW/cm 2 ) (Pyler) light, and the light stream, transformed by polarization, that lacks both ultraviolet and a significant part of the infrared rays. Studies conducted at the end of the last century proved a positive effect of physiotherapeutic procedures using this light for treatment of diseases with lesions of peripheral nerves [8, 9, 10] . The aim of the study is to increase the effectiveness of treatment of neuropathic pain in patients with diabetic polyneuropathy by including light therapy procedures into the complex treatment of this disease. [12] . The duration of the procedure was 10 minutes with a directed flow of light on the lower limbs. General characteristic features of patients with diabetes are presented in Table 1 .
Methods
Clinical examination of patients was performed before the treatment and on the 12 th day after the beginning of the treatment.
Neuropathic pain was diagnosed using the modified questionnaire dn4 (2005) [13, 14] . the questionnaire structure included two blocks of questions: 7 questions of the first block revealed sensory symptoms, including spontaneous pain (burning, painful cold, electric shocks), paresthesia and dysesthesia (tingling, pins and needles, numbness, itching); three conclusions of the physician, based on the clinical examination, which comprised the second block, give the physician the opportunity to identify the allodynia and negative sensory symptoms. Neuropathic pain was set at a score of 4 or more points.
For the details of each question, we modified the DN4 questionnaire by ranging the intensity (scale 1 to 10) of the sensations listed in the first question block.
Evaluation of the results was carried out at the admission of patients to the hospital and in 12 days after the start of diabetic polyneuropathy treatment. long-term results of the therapy were administered in 3 and 6 months by performing the call-in poll among the patients using the first question block of the questionnaire.
The analysis and processing of statistical data of clinical examinations results were carried out on a personal computer using StatiStiCa 10 and MS excel xP application packages. All data are pre sented as mean value and standard deviation (M±σ). Relations between continuous va riables were examined by the Pearson corre lation coefficient χ². Comparison of the rates between the groups was carried out using the Student T-test, and those within the group were compared using Wilcoxon matched paired test. the difference in rates was considered statis tically significant at p<0.05.
Results
According to the DN4 questionnaire, 49 (73.1 %) of the surveyed patients suffered neuropathic pain before treatment, which is consistent with the literature [15] . no significant differences between the groups were noticed before treatment (p>0.05) ( Table 2) . Subjective symptoms in the general group of patients were presented as follows: 67.2 % of patients suffered burning sensation, while 31.34 % experienced painful cold. 74.6 % of people were disturbed by tingling. 40.29 % of patients with diabetes sensed electric shocks. Pins and needles sensation and that of numb ness troubled 58.2 % and 59.7 % of patients respectively. 34.3 % of respondents had complains of itching. the objective examination of the patients' lower extremities proved that the pain was localized in the area with a reduced sensitivity to touching (in 70.2 %), pricking (in 37.3 %) and in the area of irritation with a brush (in 19.4 %), indicating a tactile and sensory sensitivity disturbance. The intensity of each of the following complaints before treatment in the examined groups of patients is presented in fig. 1 .
After the course of treatment, a decrease in the level of neuropathic pain was evidenced, together with a positive dynamics of the intensity of subjective complaints of the patients.
The analysis of data of the DN4 questionnaire proved a decrease in the signs of neuropathic pain by 41.7 % (χ²=2.5; p>0.05) in the patients of control group, and by 64.0 % (χ²=27.6; p˂0.05) in the group with additional light therapy procedures. The rate of neuro pa thic pain presence after the course of treatment was much lower in the 2 nd group. The study of individual rates of neuropathic pain in each of the groups on the 12 th day after the beginning of treatment proved that the patients of the 1 st and the 2 nd groups experienced burning sensation decrease by 15.6 % (χ²=1.6; p>0.05) and 34.4 % (χ²=6.9; p˂0.05) respectively. Painful cold sensation insignificantly decreased by 6.3 % (χ²=0.291; p>0.05) in group 1 and by 5.7 % (χ 2 =0.3; p>0.05) in group 2. The sensation of electric shocks was reduced by 28.13 % (χ²=6.5; p˂0.05) in the patients of the 1 st group and by 28.13 % (χ²=5.9; p˂0.05) in those of group 2. Tingling worried the patients with diabetes less by 15.6 % (χ²=1.6; p>0.05) of group 1 and р2 -significant differences of indexes in 12 days and in 3 months after treatment;
р3 -significant differences of indexes before and in 3 months after treatment;
р4 -significant differences of indexes in 12 days and in 6 months after treatment;
р5 -significant differences of indexes before and in 6 months after treatment.
Before treatment In 12 days after treatment
In 3 months after treatment In 6 months after treatment
Notes: sensation of 1 -burning; 2 -painful cold; 3 -electric shocks; 4 -tingling; 5 -pins and needles; 6 -numbness; 7 -itching; * -р˂0.05.
Fig. 1. Comparison of the intensity of complaints between the patient groups undergoing treatment

Discussion
The results of our study are consistent with the recent literature [1] . 1 % (χ²=0.1; p>0.05 ) and by 14.3 % (χ²=1.7; p>0.05) those in the 2 nd group. The pain, which was localized in the area of reduced sensitivity to touching, decreased by 15.6 % (χ²=1.9; p>0.05) and 14.3 % (χ 2 =1.4; p>0.05), to pricking by 25 % (χ²=4.4; p˂0.05) and 22,9 % (χ²=4.6; p˂0.05), and to irritation with a brush by 6,5 % (χ²=0.3; p>0.05) and 5.71 % (χ²=0.7; p˂0.05) in the examined groups 1 and 2, respectively ( Table 3 ).
The survey of the patients in 3 months after the treatment, proved that in the 1 st group such sensations as burning, painful cold, electric shocks, tingling, pinsand needles, numbness and itching were experienced by 17 (53.1 %), 10 (31.3 %), 12 (37.5 %), 20 (62.5 %), 10 (31.3 %), 18 (56.3 %) and 9 (28.1 %) patients, whereas in the 2 nd group -by 7 (20 %), 8 (22.9 %), 6 (17.1 %), 23 (65.7 %), 14 (40 %), 11 (31.4 %) and 7 (20 %) patients respectively.
The analysis of survey of the patients with diabetes mellitus, conducted in 6 months after the treatment, proved that the patients with diabetes had sensations of burning, painful cold, electric shocks, tingling, pins and needles, numbness and itching in 22 (68.5 %), 12 (37.5 %), 14 (43.8 %), 22 (68.5 %), 15 (46.9 %), 21 (65.6 %) and 9 (28.1 %) cases in group 1, and in 23 (65.7 %), 10 (28.6 %), 13 (37.1 %), 26 (74.3 %), 20 (57.1 %), 14 (40 %) and 12 (34.3 %) cases in group 2 respectively. The comparison of complaints intensity between the patient groups is presented in Fig. 1 .
The results of our study are consistent with the recent literature [1] . The standard therapy (α-lipoic acid, actovegin and complex of vitamins of the group B) decreases the intensity of pain and neuropathic disorders [11] . The adding of light therapy procedures allows not only the achievement of this effect, but also its long-term preservation [10, 12] . The use of the questionnaire DN4 has long been practiced for the diagnosis of neuropathic pain [13, 14] , but only its modification [9] allows evaluating the therapy effectiveness. The obtained results prove that significant improvement in the dn4 questionnaire's quantitative indicators occurred in 12 days after the beginning of treatment and persisted for three months after the treatment Conclusions using a modified dn4 questionnaire in the patients with type 2 diabetes can improve the diagnosis of neuropathic pain.
The presence of phototherapeutic procedures by the Bioptron together with the standard complex therapy of diabetic polyneuropathy has a pronounced clinical effect and contributes to a 3-month-long reduction of quantitative and qualitative indicators of neuropathic pain.
The temporary clinical effect of the use of polarizing light in the treatment of diabetic polyneuropathy proves the feasibility of studying new therapies that would influence the pathogenesis of neuropathic pain.
